iNOS inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for iNOS inhibitor, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) [Phase 2]